Many health professionals have little to no experience with cannabis therapeutics and are not able to guide people on this subject. So Project CBD has created a beginner’s guide to cannabidiol & cannabis therapeutics to address key questions of CBD users.
The 2016 meeting of the International Cannabinoid Research Society focused on the latest research in cannabinoid studies and the endocannabinoid system.
Clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1. Cannabidiol is a profound mood-altering substance, even if it may not have a “high”.
A recent Care by Design survey of 300 patients suggests that cannabis is better than Big Pharma meds for PTSD issues.
Kevin McKernan on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine.”